Symbyax and Hiv infection - a phase IV clinical study of FDA data

Summary:

Hiv infection is reported only by a few people who take Symbyax.

The phase IV clinical study analyzes which people take Symbyax and have Hiv infection. It is created by eHealthMe based on reports of 1,338 people who have side effects while taking Symbyax from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

1,338 people reported to have side effects when taking Symbyax.
Among them, 2 people (0.15%) have Hiv infection.


What is Symbyax?

Symbyax has active ingredients of fluoxetine hydrochloride; olanzapine. It is often used in depression. eHealthMe is studying from 1,440 Symbyax users for its effectiveness, alternative drugs and more.

What is Hiv infection?

Hiv infection is found to be associated with 781 drugs and 469 conditions by eHealthMe.

Number of Symbyax and Hiv infection reports submitted per year:

Could Symbyax cause Hiv infection?

Time on Symbyax when people have Hiv infection *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hiv infection when taking Symbyax *:

  • female: 0.0 %
  • male: 100 %

* Approximation only. Some reports may have incomplete information.

Do you take Symbyax and have Hiv infection?

Check whether Hiv infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Hiv infection and when was it recovered:

Expand to all the drugs that have ingredients of fluoxetine hydrochloride; olanzapine:

Alternative drugs to, pros and cons of Symbyax:

Common Symbyax side effects:

Browse all side effects of Symbyax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hiv infection treatments and more:

COVID vaccines that are related to Hiv infection:

Common drugs associated with Hiv infection:

All the drugs that are associated with Hiv infection:

Common conditions associated with Hiv infection:

All the conditions that are associated with Hiv infection:

How the study uses the data?

The study uses data from the FDA. It is based on fluoxetine hydrochloride; olanzapine (the active ingredients of Symbyax) and Symbyax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: